Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

The remarkable advances in next-generation sequencing technology have enabled the wide usage of sequencing as a clinical tool. To promote the advance of precision oncology for breast cancer in China, here we report a large-scale prospective clinical sequencing program using the Fudan-BC panel, and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Guan-Tian, Jiang, Yi-Zhou, Shi, Jin-Xiu, Yang, Fan, Li, Xiao-Guang, Pei, Yu-Chen, Zhang, Chen-Hui, Ma, Ding, Xiao, Yi, Hu, Peng-Chen, Wang, Hai, Yang, Yun-Song, Guo, Lin-Wei, Lu, Xun-Xi, Xue, Meng-Zhu, Wang, Peng, Cao, A-Yong, Ling, Hong, Wang, Zhong-Hua, Yu, Ke-Da, Di, Gen-Hong, Li, Da-Qiang, Wang, Yun-Jin, Yu, Ying, Shi, Le-Ming, Hu, Xin, Huang, Wei, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656255/
https://www.ncbi.nlm.nih.gov/pubmed/33173047
http://dx.doi.org/10.1038/s41467-020-19342-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656255/
https://www.ncbi.nlm.nih.gov/pubmed/33173047
http://dx.doi.org/10.1038/s41467-020-19342-3

Ejemplares similares